Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

about

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver.

P2860

Q52982266-8815B045-4FF4-4E0F-8B80-004BB16E2699

P2860

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

Item

http://www.wikidata.org/entity/Q43181572

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

@en

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

@nl

type

Item

label

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

@en

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

@nl

prefLabel

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

@en

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

@nl

P1476

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma

@en

P2093

Christian Cahlin

http://www.w3.org/2001/XMLSchema#string

Christoffer Hansson

http://www.w3.org/2001/XMLSchema#string

Ilan Ben-Shabat

http://www.w3.org/2001/XMLSchema#string

Malin Sternby Eilard

http://www.w3.org/2001/XMLSchema#string

Per Lindnér

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.

Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit.

Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.

Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.

Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.

Current and emerging treatment options for uveal melanoma.

Anesthetic considerations during liver surgery.

Hepatic surgical anatomy.

Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases

P304

52490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3791/52490

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P50

Magnus Rizell

Roger Olofsson Bagge

Jan E Mattsson

P577

2015-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272075159

http://www.w3.org/2001/XMLSchema#string

P698

25650893

http://www.w3.org/2001/XMLSchema#string

P932

4354564

http://www.w3.org/2001/XMLSchema#string

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

about

P2860

P2860

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P50

P577

P5875

P698

P932